跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Rimactazid - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Rimactazid
Approved
STANDARD
Rimactazid
Interphil Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
e199100e0ada6549
Company
Interphil Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
e199100e0ada6549
Drug Approval Philippines Name
Rimactazid
Product Name
Rimactazid
Registration Number
DRP-5099
Brand Name
Rimactazid
Generic Name
Rifampicin + Isoniazid
Dosage Form
Film-Coated Tablet
Dosage Strength
450 mg/400 mg
Manufacturer
Interphil Laboratories, Inc.
Trader
Sandoz Philippines Corporation
Issuance Date
24 January 2025
Expiry Date
07 June 2030
Pharmacologic Category
Antituberculosis
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
e199100e0ada6549
Type
Standard
Back to Philippines FDA Approvals